BioSpace News Archive

the Cystic Fibrosis Registry Global Harmonization Group, including the Cystic Fibrosis Foundation, published findings from the first global study on the impact of COVID-19 on children with cystic fibrosis.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Antengene Corporation for the development of a systems pharmacology modeling in immuno-oncology.

Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, today announced that Charles Huiner has been named President and Chief Executive Officer (CEO)

Molluscum contagiosum is a common and highly contagious skin condition caused by a virus. According to dermatologists from the American Academy of Dermatology, the condition mostly affects children — adults are often immune to the infection — and causes pearly, flesh-colored bumps to appear on the skin.

Medline announced a $235 million prime vendor partnership with OU Medicine Inc., a leading regional health provider in Oklahoma.

- Tolperisone was comparable to placebo on driving performance; cyclobenzaprine, market leading skeletal muscle relaxant, was significantly worse at all time points - Tolperisone similar to placebo on three measures of sleepiness whereas cyclobenzaprine displayed significantly more sleepiness

OneEvent Technologies, Inc. is proud to announce its new innovation, the Thermo Heartbeat TM algorithm. Utilizing predictive analytics and Internet of Things (IoT) technology, OneEvent monitors refrigeration temperatures while predicting the potential breakdown of refrigerators and freezers to help protect COVID-19 vaccine inve

Timber Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, announcedthat it will be presenting at the 13th annual LD Micro Main Event investor conference on Tuesday, December 15, 2020 at 10:40 AM EST / 7:40 AM PST.

Neuronetics, Inc., a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced it has amended its term loan agreement with its current lenders, investment affiliates managed by Solar Capital Partners, LLC.

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering